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ABSTRACT 
Background. No study has so far explored differences in discrimination reported by people 
with Major Depressive Disorder (MDD)  across countries and cultures. 
Aims. In people with MDD: to (1) compare reported discrimination across different 
countries; (2) explore the relative weight of individual and contextual factors in explaining 
levels of reported discrimination. 
Method. Cross-sectional multisite international survey (34 countries worldwide) on 1082 
people with MDD. Experienced and anticipated discrimination were assessed by the 
Discrimination and Stigma Scale (DISC). Countries were classified according to their level of 
Human Development Index (HDI). Multilevel negative binomial and Poisson models were 
used. 
Results. People living in  ‘veƌǇŚŝŐŚ,/ ?ĐŽƵŶƚƌŝĞƐƌĞƉŽƌƚĞĚŚŝŐŚĞƌĚŝƐĐƌŝŵŝŶĂƚŝŽŶƚŚĂŶthose 
in  ‘ŵĞĚŝƵŵ ?ůŽǁ ,/ ? ĐŽƵŶƚƌŝĞƐ. Variation in reported discrimination across countries was 
only partially explained by individual-level variables. The contribution of country-level 
variables was significant for anticipated discrimination only. 
Conclusions. Contextual factors play an important role in anticipated discrimination. 
Country-specific interventions should be implemented to prevent discrimination towards 
people with MDD. 
 
Declaration of interest. None 
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INTRODUCTION 
Major depression is the second leading cause of global disability in the world and the 
eleventh leading cause of global burden1. Although a number of effective treatments are 
currently available, fewer than half of people with depression worldwide receive adequate 
care2. Among barriers to treatment, stigma and discrimination related to mental disorders 
play a crucial role3. 
Mental ill-health discrimination is universally experienced and influences many aspects of 
ƉĞŽƉůĞ ?Ɛ ůives: it represents a barrier to social integration, it limits life opportunities and 
negatively impacts help-seeking behaviour; it produces changes in feelings and attitudes for 
both patients (lower self-esteem, poorer self-care, and social withdrawal) and their family 
members (feelings of guilt, shame, despair) 4 . 
Although the literature shows that participants in studies across the world express largely 
similar types of expectations and experiences of mental ill-health discrimination, some 
cultural specificities do exist5,6. Empirical evidence demonstrates differences in symptom 
expression and understanding of illness, and cultural influences have been noted in care 
seeking and public acceptance of the illness 7,8.  
However, findings from studies in different cultural contexts are difficult to compare, since 
research in this field has been conducted by using inconsistent and/or heterogeneous 
methodologies. Moreover, a considerable amount of information comes from research 
conducted among ethnic minorities living in western countries, such as the USA 9-11 or the 
UK12, rather than on populations living in their own countries. In addition, cross-cultural 
research has mainly addressed stigma related to schizophrenia13,14 or mental disorders in 
general15,16, rather than depression specifically. Still, a few studies have shown that this 
latter condition has better public acceptance than schizophrenia6,17,18; it could therefore be 
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expected that some specificities in depression-related stigma may exist. Further, cross-
cultural research in this field has generally focused on attitudes of the general population 
towards mental disorders or people suffering from mental disorders10,16,19,20, rather than on 
the ways in which behavioral consequences of stigma (discrimination) are experienced by 
people with depression21. Finally, the few existing cross-national comparative studies on 
stigma and discrimination related to depression have been carried out in western countries 
only22-24.  
To fill these knowledge gaps, the present explanatory study was undertaken which aims, for 
people with Major Depressive Disorder (MDD), to: (1) compare reported discrimination 
across different countries in the world; and (2) explore the relative weight of individual and 
contextual factors in explaining levels of reported discrimination.  
 
METHOD 
Design 
Data were collected within the frame of the EU-funded ASPEN (Anti Stigma Programme 
European Network) study, which was nested within the larger INDIGO-Depression 
(International Study of Discrimination and Stigma for Depression) research network. Full 
details on the ASPEN/INDIGO-depression study are given elsewhere25. Overall, 40 sites in 34 
countries worldwide were included [Africa: Egypt, Morocco, Nigeria (4 sites), Tunisia; 
America: Brazil, Canada, Venezuela. Asia: India, Japan, Malaysia, Pakistan, Sri Lanka, Taiwan. 
Europe: Belgium, Bulgaria, Croatia, Czech Republic, Finland, France, Germany, Greece, 
Hungary, Italy (2 sites), Lithuania, Netherlands, Portugal, Romania, Serbia, Slovakia, Slovenia, 
Spain, Turkey, United Kingdom (2 sites); Oceania: Australia].  
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Participants 
This was intentionally a pragmatic study25 in which many low- and middle-income countries 
were included who participated using only locally available resources as no external grant 
provision was available. Within centres, site directors were asked to identify a minimum of 
25 participants who were, in their judgment, reasonably representative (as a group) of all 
people with a diagnosis of MDD attending specialist mental health services (either 
outpatient or day-care in both the public and private sectors in the local area). The minimum 
number of 25 for each site was defined for feasibility issues, particularly for non European 
sites with no grant support. This method, used in our previous schizophrenia study26, was 
intended to allow local staff to take into account the specific local service configuration and 
to draw participants from the whole range of appropriate local services. Staff in each site 
ensured that the sample had a spread across adult age range [young people (18-25), working 
years (25- ? ? ) ?ŽůĚĞƌĂĚƵůƚƐ ?A? ? ? ) ?ĂŶĚclear representation of female participants as MDD is 
twice as prevalent in women as men. Inclusion criteria were: (i) clinical diagnosis of MDD 
(single episode or recurrent) according to DSM-IV-TR criteria during the previous 12 months 
(diagnosis had been made by ƉĂƚŝĞŶƚƐ ?treating clinicians at the time of treatment contact 
and was not reassessed at the time of study recruitment); (ii) written informed consent to 
participate; (iii) ability to understand and speak the main local language; and (iv) aged 18 or 
older. Exclusion criteria were: (i) being a psychiatric in-patient at time of recruitment; (ii) 
having a co-morbid diagnosis of schizophrenia (other co-morbidities were accepted). The 
ASPEN/INDIGO-depression study was approved by the appropriate ethical review board in 
each study site. 
 
Measures 
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Participants were assessed face-to-face by independent researchers not involved in the care 
process using the discrimination and stigma scale (version 12; DISC-12) - a structured mix-
method interview for recording the discrimination experienced by an individual with a 
mental disorder. Full details of the psychometric properties of this scale are reported 
elsewhere27. DISC-12 contains 32 questions about aspects of everyday life including work, 
marriage, parenting, housing, leisure and religious activities. Items 1 W21 are to ascertain 
ĞǆƉĞƌŝĞŶĐĞĚ ĚŝƐĐƌŝŵŝŶĂƚŝŽŶ  ?Ğ ?Ő ? ?  “,ĂǀĞ ǇŽƵ ďĞĞŶ ƚƌĞĂƚĞĚ ƵŶĨĂŝƌůǇ ŝŶ ŵĂŬŝŶŐ Žƌ ŬĞĞƉŝŶŐ
ĨƌŝĞŶĚƐ ? ? ) ? ? ? W ? ? ?ĂŶƚŝĐŝƉĂƚĞĚĚŝƐĐƌŝŵŝŶĂƚŝŽŶ ?Ğ ?Ő ? ? “,ĂǀĞǇŽƵƐƚŽƉƉĞĚǇŽƵƌƐelf from applying 
ĨŽƌǁŽƌŬ ? ? ) ? ? ?ĂŶĚ ? ? ?ƉŽƐŝƚŝǀĞƚƌĞĂƚŵĞŶƚ ?Ğ ?Ő ? ? “,ĂǀĞǇŽƵďĞĞŶƚƌĞĂƚĞĚŵŽƌĞƉŽƐŝƚŝǀĞůǇďǇ
ǇŽƵƌ ĨĂŵŝůǇ ? ? ) ? ĂŶĚ  ? ? W ? ? ? ĐŽƉŝŶŐ ƐƚƌĂƚĞŐŝĞƐ ƚŽ ŽǀĞƌĐŽŵĞ ĚŝƐĐƌŝŵŝŶĂƚŝŽŶ  ?Ğ ?Ő ? ?  “,ĂǀĞ ǇŽƵ
been able to use your personal skills or abilities in copŝŶŐǁŝƚŚƐƚŝŐŵĂĂŶĚĚŝƐĐƌŝŵŝŶĂƚŝŽŶ ? ? ) ?
WĂƌƚŝĐŝƉĂŶƚƐ ? ƌĞƐƉŽŶƐĞƐ ǁĞƌĞ ƌĂƚĞĚ ǁŝƚŚ Ă  ?-point Likert scale (0=no difference, 1=a little 
different, 2=moderately different, and 3=a lot different). The DISC-12 items were divided 
into four subscales - experienced discrimination (0 W21), anticipated discrimination (0 W4), 
overcome discrimination, and positive treatment. Only the first two subscales will be 
addressed here. For each subscale a total score is generated by counting the number of 
items in which participants score 1, 2, or 3. DISC-12 also allows qualitative information to be 
gathered to add detail to the experiences rated, providing a strong validation for the 
occurrence, direction, and severity of the discrimination rated quantitatively, which is not 
discussed in this report but will be reported upon elsewhere. Socio-demographic and clinical 
information (years since first contact with mental health services, type of mental health 
care, lifetime number of depressive episodes, admission to psychiatric hospital, advantage of 
having received a diagnosis of MDD as an explanation for ŽŶĞ ?Ɛ ŽǁŶmental health 
problems) are also recorded. 
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Stratification of ASPEN/INDIGO study sites 
The ASPEN/INDIGO-depression countries were grouped according to their Human 
Development Index (HDI), a summary measure of human development produced by the 
United Nations (for this study we used 2010 data; UNDP, 2010)28. The HDI measures the 
average achievements of a country in three basic dimensions of human development: a) a 
long and healthy life; b) access to knowledge; c) a decent standard of living. The three 
dimensions are measured by: a) life expectancy at birth (data source: UNDESA United 
Nations Department of Economic and Social Affairs 2009); b) mean years of schooling (data 
sources: population censuses and household survey data compiled by UNESCO, EUROSTAT 
and others) and expected years of schooling (data source: UNESCO Institute for Statistics 
2010); c) gross national income (GNI) per capita (data source: World Bank 2010 and IMF 
2010). Countries are ranked by their HDI value. HDI classification is based on quartiles and 
ĚĞŶŽƚĞĚ ĂƐ  ‘ǀĞƌǇ ŚŝŐŚ ? ?  ‘ŚŝŐŚ ? ?  ‘ŵĞĚŝƵŵ ? ĂŶĚ  ‘ůŽǁ ? ,/ ? ^WE ?/E/'K-depression 
ƉĂƌƚŝĐŝƉĂƚŝŶŐ ĐŽƵŶƚƌŝĞƐ ǁĞƌĞ ŐƌŽƵƉĞĚ ĂƐ ĨŽůůŽǁƐ P  ‘ǀĞƌǇ ŚŝŐŚ ,/ ?  ?ƵƐƚƌĂůŝĂ ? EĞƚŚĞƌůĂŶĚƐ ?
Canada, Germany, Japan, France, Finland, Belgium, Spain, Greece, Italy, UK, Czech Republic, 
Slovenia, Slovakia, Hungary, PortugĂů ) ?  ‘ŚŝŐŚ ,/ ?  ?>ŝƚŚƵĂŶŝĂ ? ZŽŵĂŶŝĂ ? ƌŽĂƚŝĂ ? DĂůĂǇƐŝĂ ?
ƵůŐĂƌŝĂ ?^ĞƌďŝĂ ?ƌĂǌŝů ?sĞŶĞǌƵĞůĂ ?dƵŶŝƐŝĂ ?dƵƌŬĞǇ ) ?ĂŶĚ ‘ŵĞĚŝƵŵ ?ůŽǁ,/ ? ?^ƌŝ>ĂŶŬĂ ?ŐǇƉƚ ?
DŽƌŽĐĐŽ ? /ŶĚŝĂ ? EŝŐĞƌŝĂ ? WĂŬŝƐƚĂŶ ? dĂŝǁĂŶ ) ? dŚĞ ĐĂƚĞŐŽƌŝĞƐ  ‘ŵĞĚŝƵŵ ? ĂŶĚ  ‘ůŽǁ ? ǁĞƌĞ ƉƵƚ
together as NigeriĂǁĂƐƚŚĞŽŶůǇ ‘ůŽǁ,/ ?ĐŽƵŶƚƌǇ ? 
 
Statistical analysis  
Analyses were performed by Stata 13.0 for Windows. All p-values were two-tailed with an 
accepted significance level of 0.05. Categorical variables were presented as percentages, and 
continuous variables were presented as mean values with standard deviations. Comparisons 
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among independent groups were performed by Chi-square and Kruskal-Wallis test, 
respectively. 
Due to the data dependencies induced by the nesting of patients (level 1) within countries 
(level 2), multilevel models were used, which allowed the simultaneous examination of the 
effects of individual level and country level variables on individual level outcomes. More 
ƐƉĞĐŝĨŝĐĂůůǇ ? ŐŝǀĞŶ ƚŚĞ ĚŝƐƚƌŝďƵƚŝŽŶ ŽĨ ĚĂƚĂ ? ŶĞŐĂƚŝǀĞďŝŶŽŵŝĂů  ? ‘ŵĞŶďƌĞŐ ? ĐŽŵŵĂŶĚ ) ǁĂƐ
ƐƵŝƚĂďůĞĨŽƌ  ‘ĞǆƉĞƌŝĞŶĐĞĚĚŝƐĐƌŝŵŝŶĂƚŝŽŶ ?ƐƵď-ƐĐŽƌĞĂŶĚƉŽŝƐƐŽŶ ? ‘ŵĞƉŽŝƐƐŽŶ ?ĐŽŵŵĂŶĚ )ĨŽƌ
 ‘ĂŶƚŝĐŝƉĂƚĞĚĚŝƐĐƌŝŵŝŶĂƚŝŽŶ ?ƐƵď-score. 
The steps in the construction of the models were: (1) study differences in reported 
discrimination among countries (M0: a multilevel model with the country effects modelled 
as random or intercept only model); (2) include individual variables (M1: experienced or 
anticipated discrimination sub-score, age, gender, marital status, working condition, 
education, advantage to have a MDD diagnosis as an explanation for one ?Ɛ own mental 
health problems, lifetime number of depressive episodes, outpatient mental health care, 
ĂĚŵŝƐƐŝŽŶ ƚŽ ƉƐǇĐŚŝĂƚƌŝĐ ŚŽƐƉŝƚĂů ) ĂƐ ĨŝǆĞĚ ĞĨĨĞĐƚƐ  ? ‘years since first contact with mental 
health ƐĞƌǀŝĐĞƐ ? ǁĂƐ ŶŽƚ ŝŶĐůƵĚĞĚ ďĞĐĂƵƐĞ ŝƚ ǁĂƐ ƐŝŐŶŝĨŝĐĂŶƚůǇ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ  ‘ůŝĨĞƚŝŵĞ
ŶƵŵďĞƌŽĨĞƉŝƐŽĚĞƐŽĨŵĂũŽƌĚĞƉƌĞƐƐŝŽŶ ? ) ?ĂŶĚ ? ? )ŝŶĐůƵĚĞŚƵŵĂŶĚĞǀĞůŽƉŵĞŶƚĐůĂƐƐŝĨŝĐĂƚŝŽŶ
for country level (M2: M1+HDI). Cross-level interactions terms were added where 
appropriate. 
The ŵƵůƚŝǀĂƌŝĂƚĞŵŽĚĞůƐD ?ĂŶĚD ?ǁĞƌĞĞƐƚŝŵĂƚĞĚŝŶƚƌŽĚƵĐŝŶŐĂƐƉĂƚŝĞŶƚƐ ?ĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐ
only those variables which were found significantly associated (p<0.05) with the dependent 
variable in the univariate multilevel models. The proportional change in variance estimates 
ŽĨƚŚĞĚŝĨĨĞƌĞŶƚŵŽĚĞůƐǁĂƐĐĂůĐƵůĂƚĞĚ ?dŚŝƐ ŝŶĚŝĐĂƚĞƐƚŚĞƉĂƌƚƚŚĂƚƉĂƚŝĞŶƚƐ ?ĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐ
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ĂŶĚ ĐŽƵŶƚƌŝĞƐ ? ,/ ĐůĂƐƐŝĨŝĐĂƚŝŽŶ ? ƌĞƐƉĞĐƚŝǀĞůǇ ? ĞǆƉůĂŝŶ ĐŽŶĐĞƌŶŝŶŐ ƚŚĞ ƚŽƚĂů ŝŶƚĞƌ-country 
variation.   
 
RESULTS 
Overall, 1082 people ǁŝƚŚ D ǁŽƌůĚǁŝĚĞ ƉĂƌƚŝĐŝƉĂƚĞĚ ŝŶ ƚŚĞ ƐƚƵĚǇ ? WĂƌƚŝĐŝƉĂŶƚƐ ?
characteristics stratified by the three HDI country groupings are shown in Table 1. 
 
(Table 1 about here) 
 
Country groups differed for all the socio-demographics considered (with exception of gender 
composition), with participants from the  ‘ŵĞĚŝƵŵ ?ůŽǁ,/ ?group showing lower mean age, 
lower educational level, higher unpaid work rate and lower retired rate. Moreover, country 
groups differed for almost all the clinical characteristics considered (with exception of 
outpatient MH care and advantage to have a MDD diagnosis), with participants from the 
 ‘ŵĞĚŝƵŵ ?ůŽǁ,/ ?group showing lower contact duration with mental health services, lower 
number of depressive episodes and lower hospitalization rates.   
 
Average scores for experienced discrimination by HDI group were  ? ? ? ? ?ƐĚ ? ? ? ? )ĨŽƌƚŚĞ ‘ǀĞƌǇ
ŚŝŐŚ ? ? ? ? ? ? ?ƐĚ ? ? ? ? )for ƚŚĞ ‘ŚŝŐŚ ?ĂŶĚ ? ? ? ? ?ƐĚ ? ? ? ? )for ƚŚĞ ‘ŵĞĚŝƵŵ ?ůŽǁ ? ?ƐĞĞ&ŝŐƵƌĞ ?Ă ) ?
 
(Insert Figure 1 about here) 
 
Average scores for anticipated discrimination by HDI group were  ? ? ? ? ?ƐĚ ? ? ? ? )ĨŽƌƚŚĞ ‘ǀĞƌǇ
ŚŝŐŚ ? ? ? ? ? ? ?ƐĚ ? ? ? ? )for ƚŚĞ ‘ŚŝŐŚ ?ĂŶĚ ? ? ? ? ?ƐĚ ? ? ? ? )for ƚŚĞ ‘ŵĞĚŝƵŵ ?ůŽǁ ? ?ƐĞĞ&ŝŐƵƌĞ ?ď ) ?
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The comparison of average scores among the three country groupings revealed significant 
between-group variation for both experienced (Kruskal-Wallis, p<0.001) and anticipated 
(Kurskal-Wallis, p<0.001) discrimination. 
 
The upper part of Table 2 shows the comparison of percentage of participants endorsing 
experience of discrimination in the various DISC-12 items among the three country 
groupings, whereas the lower part of Table 2 shows the comparison of percentage of people 
anticipating discrimination. 
 
(Insert Table 2 about here) 
 
Experiences of discrimination were more ĨƌĞƋƵĞŶƚ ŝŶ ƉĂƌƚŝĐŝƉĂŶƚƐ ůŝǀŝŶŐ ŝŶ  ‘ǀĞƌǇ ŚŝŐŚ ,/ ?
ĐŽƵŶƚƌŝĞƐƚŚĂŶ ‘ŵĞĚŝƵŵ ?ůŽǁ,/ ?ĐŽƵŶƚƌŝĞƐ ?ƚŚŝƐĚŝĨĨĞƌĞŶĐĞƌĞĂĐŚĞĚƐƚĂƚŝƐƚŝĐĂůƐŝŐŶŝĨŝĐĂŶĐĞŝŶ
most life domains, such as making or keeping friends, family, finding a job, welfare benefits, 
physical health, mental health staff and parental role (Chi-square, p<0.05). It should also be 
noted that the percentage of people reporting to have been shunned or avoided by others is 
1.6-ĨŽůĚŚŝŐŚĞƌŝŶ ‘ǀĞƌǇŚŝŐŚ,/ ?ĐŽƵŶƚƌŝĞƐƚŚĂŶ ‘ŵĞĚŝƵŵ ?ůŽǁ,/ ?ĐŽƵŶƚƌŝĞƐ ?ǁŚŝĐŚis highly 
significant difference (Chi-square, p<0.001). Only religious practices showed a reverse 
ƉĂƚƚĞƌŶ ?ǁŝƚŚĂŚŝŐŚĞƌƉĞƌĐĞŶƚĂŐĞŽĨĚŝƐĐƌŝŵŝŶĂƚŝŽŶƌĞƉŽƌƚĞĚŝŶƚŚĞ ‘ŵĞĚŝƵŵ ?ůŽǁ,/ ?ŐƌŽƵƉ ? 
WĂƌƚŝĐŝƉĂŶƚƐŽĨ ‘ǀĞƌǇŚŝŐŚ,/ ?ĐŽƵŶƚƌŝĞƐĂůƐŽƌĞƉŽƌƚĞĚŵŽƌĞĂŶƚŝcipated discrimination than 
those living in the other two country groups for all the DISC-12 domains (Chi-square, 
p<0.05). 
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Table 3 shows fixed and random parameters estimated from multilevel negative binomial 
models for experienced discrimination. A significant variation across countries was found 
(model M0, country-level variability not explained by other variables=0.13, LR test p<0.001). 
When individual-level variables were included (model M1), anticipated discrimination, socio-
demographics (age; widowed/separated/divorced marital status; unpaid work, 
unemployment or student) and clinical characteristics (previous admissions for psychiatric 
treatment; number of episodes of depression) were statistically significant and random 
variation between countries decreased by 30.8% (thus indicating that nearly one third of 
country-level variation came from differences in the population composition in each 
country). Stratification of countries according to HDI (model M2) was not statistically 
significant and consequently the between-countries variation did not change. 
 
(Insert Table 3 about here) 
 
Table 4 shows fixed and random parameters estimated from multilevel Poisson models for 
anticipated discrimination. A significant variation across countries was found (model M0, LR 
test p<0.001). When individual-level variables were included (model M1), experienced 
discrimination, age and single/non-cohabiting partner marital status were statistically 
significant and random variation between countries decreased by 37.5%. When country 
stratification according to the HDI was added (model M2), the between-countries variation 
decreased to 62.5% (thus indicating that 25% of the country-level variation came from 
differences in human development). No significant cross-level interaction was found 
between the significant individual-level experienced discrimination sub-score and the 
country-level human development index classification.    
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(Insert Table 4 about here) 
 
DISCUSSION 
Reported discrimination among people with MDD is more severe in high-income countries. 
Multilevel regression models showed that this association was not significant for 
experienced discrimination, but significant for anticipated discrimination. This finding seems 
robust since the variation between countries decreased by 62.5% after adjusting for 
individual- and country-level variables and the 25% of this decrease was explained by the 
HDI.    
The finding that anticipated discrimination differs across countries in parallel to their level of 
human development (with higher discrimination in the more developed countries) deserves 
an in-depth conceptual analysis. In the DISC-12 anticipated discrimination occurs when a 
person limits their own involvement in important aspects of everyday life due to the 
expectation of being discriminated against  (eg, when an individual does not apply for a job 
because he/she fully expects to fail in any such application). Therefore, respondents scoring 
high on the anticipated discrimination items not only anticipate discrimination, they also 
decided to give up and not pursue their goals  W ƚŚŝƐŝƐƌĞĨĞƌƌĞĚƚŽĂƐƚŚĞ ‘ǁŚǇ-ƚƌǇ ?effect29. 
Thus our findings indicate that anticipated discrimination has concrete consequences and 
ƌĞĂů ŝŵƉĂĐƚ ŽŶ ƉĞŽƉůĞ ?Ɛ ůŝǀĞƐ ǁŝƚŚ ŵŽƌĞ ƐĞǀĞƌĞ ĞĨĨĞĐƚ ĨŽƌ ƚŚŽƐĞ ůŝǀŝŶŐ ŝŶ ŚŝŐŚ-income 
countries. 
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It therefore seems that the context (as a reflection of social norms and values that are 
typical of a given socio-cultural group) matters in facilitating or hindering people with MDD 
to involve themselves in a number of important life activities. Other reasons for more 
anticipated discrimination in high-income countries may include the nature of employment, 
the broader socio-economic context, and the explanatory models of mental disorders and 
self-attribution. In this study almost twice as many patients living in high-income countries 
anticipated discrimination in the job domain, compared to those living in the least developed 
countries. The process of seeking entry (or reentry) into the job market for anyone with a 
substantial disruption in work record in highly industrialized societies is typically frustrating 
and disheartening, and can be traumatic for recovering patients30,31. In contrast, in 
traditional societies when patients recover from their symptoms, they are far more likely to 
find work and often find it much easier to reassume the work roles they had before32. 
Further, in industrialized societies, the work environment is typically impersonal and can be 
intensely competitive. Thus, even when a person recovering from a severe episode of major 
depression finds a job, the profound sense of marginality and insecurity lingers on. Work 
relationships in industrialized countries are under more bureaucratic regimentation; this is 
less likely to be the case for patients returning to traditional communal settings, since their 
work roles are more integrated with other aspects of their lives and are less likely to be 
taken away simply because of questions about their performance. 
 
Another possible reason for lower levels of anticipated discrimination in low income 
countries is the nature of community support. Most developing societies are based on 
collectivistic values33 , with primary emphasis on social relations and a range of conventions, 
rules, and roles that tend to sustain long-term relationships and make isolation unusual even 
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for the most disabled people. In contrast, in industrialized countries (where the social 
structure is generally individualistic) relationships are more likely to be bilaterally defined, 
contractual in nature, and subject to constant reevaluation and revocation34. It is thus 
plausible that the intense individualism characteristic of some Western societies might be 
not conducive to the recovery of mental ill health conditions. Along with their emphasis on 
independence, self-reliance, and personal freedom, individualistic value orientations also 
tend to foster fierce competition, frequent life changes, and alienation, and they do not 
usually provide the kind of structured, stable, and predictable environments that allow 
people with mental health conditions to recuperate at their own pace and to be reintegrated 
into society. There is initial empirical evidence that social context may make the difference 
ĨŽƌ ƉĞŽƉůĞ ǁŝƚŚ ĚĞƉƌĞƐƐŝŽŶ ƚŽ ƉĞƌĐĞŝǀĞ ƚŚĞ  ‘ŽƚŚĞƌƐ ? ĂƐ ŵŽƌĞ Žƌ ůĞƐƐ ƐƵƉƉŽƌƚŝǀĞ ĂŶĚ ?Žƌ
stigmatizing, since some recent studies found that greater community support and social 
capital are associated to less perceived discrimination 35,36.  
 
Explanatory models of mental disorders and self-attribution may also play a relevant role in 
shaping the perception of discrimination by people suffering from depression. Traditional 
societies in low income countries offer cultural belief systems that generally externalize 
ĐĂƵƐĂůŝƚǇ ŽĨ ƉƐǇĐŚŝĂƚƌŝĐ ƉƌŽďůĞŵƐ  ?ĞŐ ? 'ŽĚ ?Ɛ ǁŝůů ? <ĂƌŵĂ Žƌ ŽƚŚĞƌ ƐƵƉĞƌŶĂƚƵƌĂů ĞŶƚŝƚŝĞƐ )7,37, 
thus lessening individual and family blame. In contrast, in most high income industrialized 
countries the prevailing paradigm is based on the biomedical model where mental disorders 
are assumed to have a biological basis 38. dŚĞŶŽƚŝŽŶƚŚĂƚŵĞŶƚĂůĚŝƐŽƌĚĞƌƐĂƌĞƐŝŵƉůǇ ‘ďƌĂŝŶ
ĚŝƐĞĂƐĞƐ ?ƚŚĂƚĞǆŝƐƚĂƐƐƵĐŚŝŶŶĂƚƵƌĞŚĂƐƉƌŽǀĞĚƚŽďĞĞǆƚƌĞŵĞůǇĚĂŵĂŐŝŶŐto those suffering 
from mental ill-health conditions. This notion is responsible for unwarranted and destructive 
pessimism about the chances of recovery, and has ignored what is actually going on in these 
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ƉĞŽƉůĞ ?Ɛ ůŝǀĞƐ ? ŝŶ ƚŚĞŝƌ ĨĂŵŝůŝĞƐ ? ĂŶĚ ŝŶ ƚŚĞ ƐŽĐŝĞties they live in39. This results in 
stigmatization and rejection from the outside, and self-attribution and self-blame from the 
inside. This is in contrast to low-income countries where expectations of severe mental 
disorders are that these conditions are like any other acute illness, and societal reactions are 
in keeping with this view 40. 
 
In relation to the difference between high- and medium/low-income countries being 
particularly evident for anticipated discrimination, this may be because of a stronger and 
more visible service user movement in some high-income countries campaigning on issues of 
discrimination, which has raised awareness amongst those with mental health problems of 
discrimination they may experience. This is supported by a growing body of research 
detailing the nature and extent of discrimination across a range of settings4. As service user 
groups/movements emerge in low-income countries, it may be that people with mental 
health problems in these countries will also become more aware of the discrimination they 
may experience.  
 
Strengths and limitations  
The study has the following strengths. The use of interviews to gather direct self-reports 
from people with depression, both of discrimination that was actually experienced (rather 
than hypothetical scenarios or vignettes) and that which was anticipated. Most research on 
discrimination and depression has largely been descriptive, concerning surveys of public 
attitudes on hypothetical situations rather than how discrimination is experienced by people 
suffering from MDD. Moreover, collection of self-report on discrimination may empower 
service users by giving them a voice and acknowledge the validity of their experience.  
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This study has also several limitations. Samples sizes in the participating countries were 
relatively small. Participants were selected from treated patients rather than from people 
with MDD living in the community, thus limiting the generalizability of results to all people 
with MDD living in participating sites. Selection bias could have occurred as participants 
were recruited on the basis of access to mental health services, the judgment of local 
research staff and their willingness to participate. Moreover, due to the relatively low 
sample size in the participating countries, we could not control for possible contextual 
differences within a given country (eg, rural vs. urban / deprived vs. affluent areas). Disability 
and clinical severity measures were not used, therefore it was not easy to understand how 
far discrimination reported by respondents was more realistically attributable to disorder-
related impairments, or to negative appraisal of life circumstances influenced by current 
levels of depressive symptoms; this issue warrants further investigation. The cross-sectional 
study design does not provide evidence of causal relationships between putative predictors 
and levels of discrimination, nor about the time that it takes for stigma to develop and have 
consequences. The nature of this study was explanatory and therefore no a priori hypothesis 
was formulated about the direction of possible associations between cross-cultural 
differences and discrimination. No information was gathered on other possible minority 
statuses; this could have been a potential source of bias in case of patients with multiple 
minority statuses (eg, ethnic, religious, sexual, physical illness). Finally, social desirability is a 
common limitation of self-report stigma measures which may vary cross-culturally.  
 
Implications for future research  
Overall, the results of this study suggest that close personal relationships and informal social 
support networks may play a significant role in buffering anticipated discrimination in people 
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with ĚĞƉƌĞƐƐŝŽŶ ?ƚŚĞƌĞĨŽƌĞƚŚĞ ‘ƐŽĐŝĂůĚŝƐƚĂŶĐĞ ?ĞůĞŵĞŶƚŽĨƐƚŝŐŵĂŝƐĂŶŝŵƉŽƌƚĂŶƚĨŽĐƵƐĨŽƌ
future research. This also implies that culturally sensitive measures of social capital should 
be included in future cross-cultural research on stigma and discrimination. Moreover, we 
need more high-quality qualitative research in this field in order to gain a more in-depth 
ŝŶƐŝŐŚƚ ŽŶ ŚŽǁ ĚŝƐĐƌŝŵŝŶĂƚŝŽŶ ƌĞĂůůǇ ŝŵƉĂĐƚƐ ŽŶ ƉĞŽƉůĞƐ ? ůŝǀĞƐ ĂŶĚ ƐƚƵĚŝĞƐ ƚŚĂƚ ǁŝůů ĂůůŽǁ
relating these reported/perceived findings to the outcome of mental disorders and the 
ŝŵƉĂĐƚŽŶƉĞŽƉůĞ ?ƐůŝǀĞƐ ?>ŽŶŐŝƚƵĚŝŶĂůƐƚƵĚŝĞƐŝŶĚŝĐĂƚŝŶŐŚŽǁĂŶĚǁŚĞŶƐƚŝŐŵĂĚĞǀĞůŽƉƐĂŶĚ
how stigma and its consequences changes over time would also be very useful. 
 
A tentative agenda for future interventions 
The majority of people in high income countries tend to attribute major depression to 
neurobiological causes18. The percentage of the general public endorsing this view has 
steadily increased over the last fifteen years, in parallel with the spread of the message 
launched by some campaigns worldwide claiming that mental illness is "a disease like any 
other". However, social distance and perceived danger associated with people with 
depression has not decreased significantly over the same period in western Europe41 and the 
USA42. Holding a neurobiological conception of mental disorders seems to increase the 
likelihood of support for treatment, but it appears unrelated to stigma, and where 
associated the effect is to increase, not decrease, community rejection18,38. The assumption 
underlying a number of anti-stigma campaigns launched over the last decades in the high 
income countries (ie, educating people about biological basis of mental disorders 
automatically leads to the improvement of their attitudes towards the mentally ill) therefore 
appears questionable. Because the public holds a tacit understanding of the aetiology of 
mental illness, our efforts need to move past this message42. Reconfiguring stigma reduction 
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strategies in high income countries may require providers and advocates to shift to an 
emphasis on competence and inclusion. Efforts should prioritize inclusion, integration, 
competences for the reduction of cultural barriers to recognition, response, and recovery. 
Unless we tackle stigma at the cultural level, the prospects for changing the lives of those 
affected by mental disorders will be unlikely to happen.  
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Table 1. Socio-demographic and illness-related characteristics of the overall sample stratified by country groups 
(Very high HDI, High HDI, Medium/Low HDI) (n=1087)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
       
                                  * Chi-square for percentages and Kruskal-Wallis for means (SDs) 
                                  §  The original 11 categories were collapsed by distinguishing participants who: work and are paid, work but are not paid, do not work, and are retired 
 
 
  Very high HDI High HDI Medium/Low  HDI P* 
 
 (n=503) (n=314) (n=270) 
 
Male, %  34.0 30.3 38.5  0.110 
Age, mean (SD)   47.2 (15.3) 45.3 (14.6) 39.8 (14.0) <0.001 
Lower education, %  44.1 35.1 55.0 <0.001 
Marital status, %      
       married /cohabiting  44.4 51.6 59.0  0.001 
       single   30.5 24.0 26.1  
       widowed / separated / divorced  25.1 24.4 14.9  
Employment§, %      
       full-time / part-time  39.2 39.9 40.5 <0.001 
       volunteer / sheltered / at home  4.4 8.6 22.7  
       unemployed / student  36.5 33.9 31.5  
       retired  19.9 17.6 5.3  
Yrs since first MH contact, mean (SD)  11.7 (12.2) 9.2 (9.4) 6.4 (8.7) <0.001 
Outpatient MH care, %  87.2 82.6 84.3  0.185 
Advantage to have a diagnosis of MDD as an 
explanation for one's own MH problems, % 
 
80.8 79.0 78.6  0.737 
>ŝĨĞƚŝŵĞĚĞƉƌĞƐƐŝǀĞĞƉŝƐŽĚĞƐA? ? ?A?  41.4 30.0 25.0 <0.001 
Ever psychiatric admission, %  41.2 42.4 27.2 <0.001 
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Figure 1.  Discrimination scores by countries within groups with very high,  high  and medium/low HDI (n=1082) 
Figure 1a.   Experienced discrimination [number of items (range 0-21) in which participants reported  a disadvantage] 
Very high HDI                                                                       High HDI                                            Medium/Low HDI 
 
 
 
Figure 1b.  Anticipated discrimination [number of items (range 0-4) in which participants reported  a disadvantage] 
 Very high HDI                                                                            High HDI                                         Medium/Low HDI 
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 Table 2.  Comparison of percentages of participants with MDD reporting discrimination in the various DISC-12 items by 
country groups (Very high HDI, High HDI, Medium/Low HDI) (DIS = discriminated; NA= not applicable) 
 
 Very high HDI High HDI Medium/Low HDI P 
 DIS (%) NA (%) DIS (%) NA (%) DIS (%) NA (%) Chi-square 
Experienced discrimination (n=1082) n=501 n=312 n=269  
Making or keeping friends 41.1 6.2 30.4 7.3 27.8 1.9 <0.001 
Neighbourhood 17.2 29.6 23.2 12.7 17.8 1.5  0.116 
Dating or intimate relationships 32.5 29.6 27.3 59.6 28.0 18.9  0.348 
Housing 13.2 36.2 14.0 35.7 13.9 17.0  0.953 
Education 22.7 44.3 18.6 44.6 19.5 25.6  0.511 
Marriage or divorce 38.9 35.4 30.6 28.3 31.2 23.7  0.081 
Family  44.4 2.4 43.8 1.9 30.0 0.7 <0.001 
Finding a job 27.5 46.1 23.8 45.9 16.5 29.6  0.022 
Keeping a job 34.5 29.8 31.1 32.8 26.0 36.7  0.150 
Public transport 7.7 21.9 6.4 24.5 8.8 11.1  0.607 
Welfare benefits or disability pensions  27.8 50.1 18.0 48.1 9.4 67.8  0.001 
Religious practices 7.2 39.0 2.7 27.1 10.1 4.4  0.005 
Social life 23.1 9.9 17.0 18.8 19.7 1.5  0.149 
Police 11.1 40.4 5.4 28.7 9.6 22.6  0.073 
Physical health problems 23.1 6.6 15.1 4.1 11.8 2.6 <0.001 
Mental health staff 26.0 3.6 16.8 1.0 12.5 1.5 <0.001 
Personal privacy 14.3 3.4 20.7 5.4 19.4 2.2  0.044 
Personal safety and security 24.2 7.6 19.6 1.9 21.9 1.5  0.323 
Starting a family or having children 16.8 59.4 17.0 50.6 12.7 32.6  0.446 
Role as a parent 26.5 46.1 18.4 35.4 14.2 28.9  0.004 
Avoided or shunned by people 40.7 2.2 34.1 5.1 25.4 1.5 <0.001 
Anticipated discrimination (n=1080) n=501 n=310 n=269  
Applying for a job 48.2 38.6 40.6 35.0 27.2 27.4 <0.001 
Applying for education or training 35.2 33.0 33.7 35.7 23.3 33.0  0.019 
Close personal relationship 47.5 10.5 43.2 10.8 30.4 11.5 <0.001 
Concealed or hidden MH problems 77.7 0.8 69.0 0.6 62.4 1.1 <0.001 
DIS was obtained by combining discrimination categories 1, 2, 3 for each item 
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Table 3. Multilevel negative binomial regression models for experienced discrimination (overall sample n=1082). Only independent variables significantly 
associated (p<0.05) with the dependent variable in the univariable models were introduced in the multivariable models 
 
 
M0: Variance 
Components  
M1: M0+Patient-level 
characteristics  
M2: M1+Country-level 
Characteristics  
 Estimate (SE) p-value Estimate (SE) p-value Estimate (SE) p-value 
Fixed effects       
Intercept 1.25 (0.07) 0.000 0.88 (0.16) 0.000 0.90 (0.18) <0.001 
Patient level characteristics       
Anticipated discrimination   0.29 (0.03) 0.000 0.29 (0.03) <0.001 
Age   -0.01 (0.00) 0.001 -0.01 (0.00)  0.001 
Advantage to have a diagnosis of MDD   0.07 (0.08) 0.399 0.06 (0.08)  0.405 
Ever admitted for psychiatric treatment   0.32 (0.07) 0.000 0.32 (0.07) <0.001 
Six or more lifetime episodes of depression   0.23 (0.07) 0.001 0.23 (0.07)  0.001 
Marital status 
   Married or co-habiting 
   Single or no co-habiting partner 
   Widowed, separated or divorced 
   
Ref 
0.01 (0.08) 
0.16 (0.08) 
 
 
0.970 
0.043 
 
Ref 
0.01 (0.08) 
0.17 (0.08) 
 
 
 0.984 
 0.042 
>ŽǁĞĚƵĐĂƚŝŽŶ ?ƵƉƚŽƐĞĐŽŶĚĂƌǇ ?A䜃? ?ǇƌƐ ) ?   -0.08 (0.07) 0.255 -0.08 (0.07)  0.230 
Working condition 
   Full-time or part-time 
   Volunteer, sheltered or at home 
   Unemployed or a student 
Retired 
   
Ref 
0.26 (0.11) 
0.14 (0.07) 
-0.10 (0.12) 
 
 
0.020 
0.048 
0.410 
 
Ref 
0.26 (0.11) 
0.14 (0.07) 
-0.10 (0.12) 
 
 
 0.021 
 0.048 
 0.420 
Country level characteristics       
Human Development Index 
Very high HDI 
High HDI 
Medium/Low HDI 
     
Ref 
-0.10 (0.15) 
0.01 (0.17) 
 
 
 0.531 
 0.941 
Random effect variances       
Country level 0.13 (0.04) - 0.09(0.03) - 0.09 (0.03) - 
Proportion reduction in variance estimates 
compared to intercept only model 
  30.8%  30.8%  
LR test 87.44 0.000 42.07 0.000 37.81 <0.001 
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Table 4. Multilevel poisson regression models for anticipated discrimination (overall sample n=1080). Only independent variables significantly associated 
(p<0.05) with the dependent variable in the univariable models were introduced in the multivariable models 
 
 
M0: Variance 
Components  
M1: M0+Patient-level 
characteristics  
M2: M1+Country-level 
Characteristics  
 Estimate (SE) p-value Estimate (SE) p-value Estimate (SE) p-value 
Fixed effects       
Intercept 0.39 (0.06) 0.000 0.30 (0.15) 0.043 0.42 (0.16)  0.008 
Patient level characteristics       
Experienced discrimination   0.06 (0.01) 0.000 0.06 (0.01) <0.001 
Age   -0.01 (0.00) 0.052 -0.01 (0.00)  0.052 
Advantage to have a diagnosis of MDD   0.07 (0.07) 0.356 0.07 (0.07)  0.374 
Six or more lifetime episodes of depression   0.09 (0.07) 0.167 0.08 (0.07)  0.256 
Marital status 
   Married or co-habiting 
   Single or no co-habiting partner 
   Widowed, separated or divorced 
   
Ref 
0.16 (0.08) 
0.01 (0.08) 
 
 
0.040 
0.911 
 
Ref 
0.15 (0.08) 
-0.01 (0.08) 
 
 
 0.054 
 0.994 
Working condition 
   Full-time or part-time 
   Volunteer, sheltered or at home 
   Unemployed or a student 
Retired 
   
Ref 
-0.13 (0.11) 
0.01 (0.07) 
-0.16 (0.12) 
 
 
0.267 
0.976 
0.201 
 
Ref 
-0.08 (0.12) 
0.01 (0.07) 
-0.16 (0.12) 
 
 
 0.473 
 0.989 
 0.187 
Country level characteristics       
Human Development Index 
Very high HDI 
High HDI 
Medium/Low HDI 
     
Ref 
-0.06 (0.11) 
-0.34 (0.13) 
 
 
 0.605 
 0.007 
Random effect variances       
Country level 0.08 (0.03) - 0.05 (0.02) - 0.03 (0.02) - 
Proportion reduction in variance estimates 
compared to intercept only model 
  37.5%  62.5%  
LR test 88.45 0.000 21.86 0.000 13.30 <0.001 
 
